정형외과용 임플란트 시장 : 제품별, 생체 재료별, 신체 부위별, 수기별, 최종 사용자별, 지역별, 기회, 예측(2017-2031년)

Global orthopedic implants market is projected to witness a CAGR of 5.05% during the forecast period 2024-2031, growing from USD 41.15 billion in 2023 to USD 61.02 billion in 2031. Growth in the global orthopedic implants market is driven by various factors, such as a growing aging population, technological advancements, increasing demand for minimally invasive surgeries, and growing research and development in the industry. Increasing healthcare budgets, significant investments by public and private companies, the presence of several medical device companies, and strategies, such as mergers and acquisitions, collaborations, and product launches, are accelerating the demand for orthopedic implants globally.

The global orthopedic implants market is undergoing robust growth due to the increasing geriatric population and the growing prevalence of accidents and sports injuries. The geriatric population is more prone to health conditions, such as arthritis, fractures, and knee joint pain, due to which, there is a growing demand for orthopedics implants globally. Significant investments by public and private organizations, along with increasing government initiatives, such as granting funds for improving research and development activities and bringing innovation in orthopedic implants market, are favoring the market growth. In line with this, ongoing collaborations, such as frequent mergers and acquisitions, partnerships, and distribution agreements within the healthcare industry, are anticipated to propel the global orthopedic implants market further. Many start-ups and new medical device companies are developing innovative and technologically advanced products, thus supporting the market growth.

For instance, HAPPE Spine, a new medical device company which has entered the orthopedic implants industry, is working on developing latest innovative implants using novel materials that can improve the efficiency and productivity of the orthopedic implants and improve surgical outcomes.

Increasing Geriatric Population

As the global demographic profile shifts towards an older population, there will be an increasing demand for orthopedic implants due to age-related health conditions like osteoarthritis, fractures, and knee joint pain. As people grow older, there is a greater likelihood of joint issues that increase the demand for orthopedic implants to improve mobility and quality of life. The continuous growth of the aging population, particularly in developed countries, ensures a sustained market for orthopedic implants. For instance, according to an article published in Finance and Development 2023, the total world population crossed the 8 billion milestone in 2022. However, currently, the most prominent demographic challenge faced by the world is the growing aging population. The article states that global life expectancy will reach 72 years in 2022 and is expected to continue for the next 10 years. Due to this, the prevalence of orthopedic health conditions has also increased and led to a higher demand for orthopedic surgeries and interventions like orthopedic Implants. Manufacturers are investing in advanced implant technologies to cater to this expanding patient base, making it a key driver of market growth.

Technological Advancements

Advancements in technology play a crucial role in driving the global orthopedic implants market. The innovations in implant designs, materials, and surgical techniques lead to high demand among patients and surgeons. Additionally, the integration of AI with orthopedic implants further increases the efficiency of implants and improves implant performance, as well as patient satisfaction, making it a significant driver of market growth. For instance, in March 2023, Zimmer Biomet Holdings, Inc., a global leader in medical devices, announced the launch of its innovative product "ZBEdge Dynamic Intelligence" at the American Academy of Orthopaedic Surgeon's (AAOS) in the 2023 Annual Meeting in Las Vegas. This product integrates with Zimmer's implant technologies and connects easily and effectively for collecting insightful data. This smart implant captures key kinematic data metrics and helps the physician during patient monitoring and treatment post-surgery.

Rapid Growth of Orthopedic Implants in Minimally Invasive Surgery

Among the procedure segment, the application of orthopedic implants is driven by rapidly increasing demand for minimally invasive surgery. Minimally invasive surgery offers advantages, such as faster recovery, reduced scarring, and improved patient satisfaction due to less complicated surgical procedures. Many key market players are launching orthopedic implants, such as internal fixators, for lower extremity minimally invasive surgeries in their product portfolio. In September 2023, Stryker, announced the launch of a novel internal fixation device called "PROstep MIS Lapidus," which treats bunions by fusing the first metatarsal cuneiform joint after a minimally invasive surgical procedure to reduce the hallux valgus deformity. The introduction of robotically assisted lower extremity surgeries, a supportive regulatory environment, and rising demand for orthopedic surgeries motivate orthopedic implant manufacturers to invest and launch innovative devices.

Reconstructive Joint Replacements Held the Largest Share

Among the product segment, reconstructive joint replacements, such as knee and hip replacement implants, hold a significant market share in the global orthopedic implants market. A growing geriatric population results in a high number of joint-related disorders like osteoarthritis, rheumatoid arthritis, bursitis, which further encourages the development of orthopedic implants specially to treat these disorders. Moreover, key market players are bringing new product launches in this segment by developing advanced and highly efficient orthopedic implants. For instance, in October 2023, Medacta Group S.A., a Swiss company involved in developing and manufacturing innovative products for joint replacement, sports medicine, and spine surgeries, announced the launch of "GMK SpheriKA", which is an innovative knee implant used in total knee replacement surgery. GMK SpheriKA is the world's first kinematic alignment-optimized femoral component that uses kinematic alignment to accommodate unique anatomy of patients.

Asia-Pacific is Expected to be the Fastest Growing Region

Asia-Pacific is expected to be the fastest growing region in the global orthopedic implants market. Increasing geriatric population and rising prevalence of orthopedic conditions among the population have led to higher demand for orthopedic implants to improve health conditions and surgical outcomes, thereby favoring the market growth. Moreover, the increasing adoption of orthopedic implants in emerging countries, growing investments, and product launches by key market players in the region are also driving the growth of this market.

For instance, in August 2023, Smith+Nephew, a global leader in medical technology, announced launch of its new orthopedic implant "OR3O Dual Mobility System" in India. This product is a dual mobility implant with a small diameter femoral head, which is easily locked into a larger polyethylene insert. This increases stability, reduces chances of dislocation, and offers improved range of motion for patients with hip arthroplasty. Reimbursement policies, growing geriatric population in countries like China, Japan, and South Korea, increasing population, and advanced healthcare systems are other factors attracting various medical device companies to establish their operations in Asia Pacific.

Future Market Scenario (2024 - 2031F)

The global orthopedic implants market is expected to grow in the future primarily due to the increasing number of old age population worldwide, which has significantly increased the prevalence of orthopedic conditions like osteoarthritis, rheumatoid arthritis, fractures, severe joint injuries. Technological advancements and innovations in orthopedic implant designs and materials for improving quality of these implants will further accelerate the market growth. Growing awareness and trust among patients regarding orthopedic implants efficiency, increasing government funds for developing innovative orthopedic implants, along with new product launches by key market players are supporting the increasing demand for orthopedic implants globally. Additionally, collaborative ventures involving manufacturers of medical and surgical devices have brought innovation and growth in the global orthopedic implants market.

Key Players Landscape and Outlook

In the orthopedic implants market, surgical and medical device manufacturers consistently establish strategic partnership activities, such as mergers and acquisitions, distribution agreements, and collaborations, which are pivotal in propelling the global orthopedic implants market's expansion. These collaborations empower firms to gain insights regarding the industry's technological advancements, benefit from each other's resources, and invest in research and development for developing innovative products to improve the quality of treatment. The distribution agreements enable companies to expand their market presence on a larger scale by tapping into new regions or countries. In January 2024, Smith+Nephew, announced the successful acquisition of CartiHeal, which is well-known as the developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Orthopaedic Implants Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. By Product
  • 4.2.1. Reconstructive Joint Replacements
  • 4.2.2. Spinal Implants
  • 4.2.3. Dental Implants
  • 4.2.4. Trauma Fixation
  • 4.2.5. Orthobiologics
  • 4.2.6. Others
• 4.3. By Biomaterial
  • 4.3.1. Metallic
  • 4.3.2. Ceramic
  • 4.3.3. Polymers
  • 4.3.4. Others
• 4.4. By Body Part
  • 4.4.1. Hip
  • 4.4.2. Spine
  • 4.4.3. Knee
  • 4.4.4. Wrist & Shoulder
  • 4.4.5. Ankle
  • 4.4.6. Dental
• 4.5. By Procedure
  • 4.5.1. Open Surgery
  • 4.5.2. Minimally Invasive Surgery (MIS)
  • 4.5.3. Others
• 4.6. By End-user
  • 4.6.1. Hospitals
  • 4.6.2. Specialty Clinics
  • 4.6.3. Others
• 4.7. By Region
  • 4.7.1. North America
  • 4.7.2. Europe
  • 4.7.3. Asia-Pacific
  • 4.7.4. South America
  • 4.7.5. Middle East and Africa
• 4.8. By Company Market Share (%), 2023

5. Global Orthopaedic Implants Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. By Value
    • 5.1.1.2. By Volume
  • 5.1.2. By Product
    • 5.1.2.1. Reconstructive Joint Replacements
    • 5.1.2.2. Spinal Implants
    • 5.1.2.3. Dental Implants
    • 5.1.2.4. Trauma Fixation
    • 5.1.2.5. Orthobiologics
    • 5.1.2.6. Others
  • 5.1.3. By Biomaterial
    • 5.1.3.1. Metallic
    • 5.1.3.2. Ceramic
    • 5.1.3.3. Polymers
    • 5.1.3.4. Others
  • 5.1.4. By Body Part
    • 5.1.4.1. Hip
    • 5.1.4.2. Spine
    • 5.1.4.3. Knee
    • 5.1.4.4. Wrist & Shoulder
    • 5.1.4.5. Ankle
    • 5.1.4.6. Dental
  • 5.1.5. By Procedure
    • 5.1.5.1. Open Surgery
    • 5.1.5.2. Minimally Invasive Surgery (MIS)
    • 5.1.5.3. Others
  • 5.1.6. By End-user
    • 5.1.6.1. Hospitals
    • 5.1.6.2. Specialty Clinics
    • 5.1.6.3. Others
  • 5.1.7. United States*
    • 5.1.7.1. Market Size & Forecast
    • 5.1.7.1.1. By Value
    • 5.1.7.1.2. By Volume
    • 5.1.7.2. By Product
    • 5.1.7.2.1. Reconstructive Joint Replacements
    • 5.1.7.2.2. Spinal Implants
    • 5.1.7.2.3. Dental Implants
    • 5.1.7.2.4. Trauma Fixation
    • 5.1.7.2.5. Orthobiologics
    • 5.1.7.2.6. Others
    • 5.1.7.3. By Biomaterial
    • 5.1.7.3.1. Metallic
    • 5.1.7.3.2. Ceramic
    • 5.1.7.3.3. Polymers
    • 5.1.7.3.4. Others
    • 5.1.7.4. By Body Part
    • 5.1.7.4.1. Hip
    • 5.1.7.4.2. Spine
    • 5.1.7.4.3. Knee
    • 5.1.7.4.4. Wrist & Shoulder
    • 5.1.7.4.5. Ankle
    • 5.1.7.4.6. Dental
    • 5.1.7.5. By Procedure
    • 5.1.7.5.1. Open Surgery
    • 5.1.7.5.2. Minimally Invasive Surgery (MIS)
    • 5.1.7.5.3. Others
    • 5.1.7.6. By End-user
    • 5.1.7.6.1. Hospitals
    • 5.1.7.6.2. Specialty Clinics
    • 5.1.7.6.3. Others
  • 5.1.8. Canada
  • 5.1.9. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. Asia-Pacific
  • 5.3.1. India
  • 5.3.2. China
  • 5.3.3. Japan
  • 5.3.4. Australia
  • 5.3.5. Vietnam
  • 5.3.6. South Korea
  • 5.3.7. Indonesia
  • 5.3.8. Philippines
• 5.4. South America
  • 5.4.1. Brazil
  • 5.4.2. Argentina
• 5.5. Middle East & Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. South Africa

6. Market Mapping, 2023

• 6.1. By Product
• 6.2. By Biomaterial
• 6.3. By Body Part
• 6.4. By Procedure
• 6.5. By End-user
• 6.6. By Region

7. Macro Environment and Industry Structure

• 7.1. Demand Supply Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Clinical Trials
• 9.2. Patent Landscape
• 9.3. Regulatory Approvals
• 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. B. Braun SE
  • 13.1.1.1. Company Details
  • 13.1.1.2. Key Management Personnel
  • 13.1.1.3. Products & Services
  • 13.1.1.4. Financials (As reported)
  • 13.1.1.5. Key Market Focus & Geographical Presence
  • 13.1.1.6. Recent Developments
• 13.2. Stryker
• 13.3. CONMED Corporation
• 13.4. Medtronic Plc.
• 13.5. Johnson & Johnson's (DePuy Synthes)
• 13.6. Smith & Nephew plc
• 13.7. Globus Medical, Inc.
• 13.8. Arthrex, Inc.
• 13.9. Zimmer Biomet Holdings, Inc.
• 13.10. Medacta Group S.A.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer